Related Experiment Video
Updated: Feb 15, 2026

Quantifying Yersinia pseudotuberculosis Type III Secretion System Activity Following Iron Starvation and Anaerobic Growth
Published on: May 31, 2024
Loss of CNFY toxin-induced inflammation drives Yersinia pseudotuberculosis into persistency
Wiebke Heine1, Michael Beckstette1, Ann Kathrin Heroven1
1Department of Molecular Infection Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany.
Abstract:
Gastrointestinal infections caused by enteric yersiniae can become persistent and complicated by relapsing enteritis and severe autoimmune disorders. To establish a persistent infection, the bacteria have to cope with hostile surroundings when they transmigrate through the intestinal epithelium and colonize underlying gut-associated lymphatic tissues. How the bacteria gain a foothold in the face of host immune responses is poorly understood. Here, we show that the CNFY toxin, which enhances translocation of the antiphagocytic Yop effectors, induces inflammatory responses. This results in extensive tissue destruction, alteration of the intestinal microbiota and bacterial clearance. Suppression of CNFY function, however, increases interferon-γ-mediated responses, comprising non-inflammatory antimicrobial activities and tolerogenesis. This process is accompanied by a preterm reprogramming of the pathogen's transcriptional response towards persistence, which gives the bacteria a fitness edge against host responses and facilitates establishment of a commensal-type life style.
Insights
The CNFY toxin from enteric yersiniae initially causes inflammation and tissue damage, but suppressing it promotes bacterial persistence. This discovery offers insights into managing persistent gastrointestinal infections.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Enteric yersiniae infections can lead to persistent enteritis and autoimmune disorders.
- Bacterial survival during intestinal transmigration and colonization relies on overcoming host immune responses.
- Mechanisms by which yersiniae establish persistent infections are not fully understood.
Purpose of the Study:
- To investigate the role of the CNFY toxin in enteric yersiniae pathogenesis.
- To understand how CNFY influences host immune responses and bacterial persistence.
- To explore strategies for controlling persistent yersiniae infections.
Main Methods:
- Analysis of CNFY toxin function in vitro and in vivo.
- Assessment of host immune responses, including inflammatory markers and interferon-gamma.
- Microbiota analysis and bacterial transcriptional profiling.
Main Results:
- The CNFY toxin induces inflammatory responses, leading to tissue destruction and bacterial clearance.
- Suppression of CNFY enhances interferon-gamma-mediated antimicrobial activities and tolerogenesis.
- Reduced CNFY function triggers early bacterial transcriptional reprogramming towards persistence.
Conclusions:
- CNFY toxin plays a dual role in yersiniae infections, initially promoting inflammation but its suppression facilitates persistence.
- Interferon-gamma mediated responses are crucial for controlling yersiniae, and CNFY suppression redirects bacterial strategy towards a commensal lifestyle.
- Targeting CNFY function could offer new therapeutic avenues for managing persistent enteric yersiniae infections.
Related Concept Videos
Inflammation
Types of Toxins
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Line Loss
Line loss impacts power delivery efficiency in a balanced three-phase circuit. The symmetry in such a circuit simplifies the...
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

